reverse primer: 5'-AAAAAAAGCACCGACTCGGTGCCAC-3') amplification were transcribed with the Transcript Aid T7 High Yield Transcription Kit (Thermo Fisher Scientific) and purified with the miRNeasy Mini Kit (Qiagen).
Establishment of X. tropicalis ptf1a/p48 mutant line
In our previous study, we had generated ptf1a/p48 founder frogs with CRISPR/Cas9 [2] . From one such male founder, we obtained a pool of ptf1a/p48 heterozygous F2 frogs including males and females carrying the same genotype. Homozygous tadpoles were obtained by crossing these F2 frogs via natural mating. Several mating experiments revealed that homozygous tadpoles could not survive beyond stage 48.
Some of the tadpoles at stage 43 were collected for whole mount in situ hybridization analysis.
Evaluation of gene targeting efficiency in gRNA/Cas9-injected X. laevis embryos
The targeting efficiency was examined at 48 hours after microinjection. We randomly collected five healthy embryos from each injection, extracted genomic DNA, amplified the targeted region by PCR (for primers see Table S2 ), and then cloned the purified PCR amplicons into the pMD18-T vector (Takara) by TA cloning. 10-20 single colonies were randomly picked for DNA sequencing analysis to detect any insertion or deletion (indel) mutations resulting from error-prone non-homologous end joining (NHEJ)-based repair of Cas9-created double-strand breaks. The targeting efficiency was determined by the ratio of mutant to total colonies sequenced. 
